Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Non-invasive tumor decoding and phenotyping of cerebral gliomas utilizing multiparametric 18F-FET PET-MRI and MR Fingerprinting.
Haubold J, Demircioglu A, Gratz M, Glas M, Wrede K, Sure U, Antoch G, Keyvani K, Nittka M, Kannengiesser S, Gulani V, Griswold M, Herrmann K, Forsting M, Nensa F, Umutlu L. Haubold J, et al. Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1435-1445. doi: 10.1007/s00259-019-04602-2. Epub 2019 Dec 6. Eur J Nucl Med Mol Imaging. 2020. PMID: 31811342
DSM-TACE of HCC: Evaluation of Tumor Response in Patients Ineligible for Other Systemic or Loco-Regional Therapies.
Haubold J, Reinboldt MP, Wetter A, Li Y, Ludwig JM, Lange C, Wedemeyer H, Schotten C, Umutlu L, Theysohn J. Haubold J, et al. Rofo. 2020 Sep;192(9):862-869. doi: 10.1055/a-1111-9955. Epub 2020 Mar 4. Rofo. 2020. PMID: 32131109 Free article. English.
Patients treated with DSM-TACE showed an overall good median survival of 682 days, strictly dependent on BCLC stage.. CITATION FORMAT: . Haubold J, Reinboldt MP, Wetter A et al. DSM-TACE of HCC: Evaluation of Tumor Response in Patients Ineligible for Other Systemic …
Patients treated with DSM-TACE showed an overall good median survival of 682 days, strictly dependent on BCLC stage.. CITATION FORMAT: . …
Comparison of 18F-FDG PET-MR and fecal biomarkers in the assessment of disease activity in patients with ulcerative colitis.
Li Y, Khamou M, Schaarschmidt BM, Umutlu L, Forsting M, Demircioglu A, Haubold J, Koch AK, Bruckmann NM, Sawicki LM, Herrmann K, Boone JH, Langhorst J. Li Y, et al. Among authors: haubold j. Br J Radiol. 2020 Aug;93(1112):20200167. doi: 10.1259/bjr.20200167. Epub 2020 Jun 24. Br J Radiol. 2020. PMID: 32579403 Free PMC article. Clinical Trial.
Diagnostic Performance of Simultaneous [18F]-FDG PET/MR for Assessing Endoscopically Active Inflammation in Patients with Ulcerative Colitis: A Prospective Study.
Langhorst J, Umutlu L, Schaarschmidt BM, Grueneisen J, Demircioglu A, Forsting M, Beiderwellen K, Haubold J, Theysohn JM, Koch AK, Dobos G, Dechêne A, Herrmann K, Bruckmann NM, Lauenstein T, Li Y. Langhorst J, et al. Among authors: haubold j. J Clin Med. 2020 Aug 1;9(8):2474. doi: 10.3390/jcm9082474. J Clin Med. 2020. PMID: 32752196 Free PMC article.
Three-dimensional Magnetic Resonance Imaging-based Printed Models of Prostate Anatomy and Targeted Biopsy-proven Index Tumor to Facilitate Patient-tailored Radical Prostatectomy-A Feasibility Study.
Darr C, Finis F, Wiesenfarth M, Giganti F, Tschirdewahn S, Krafft U, Kesch C, Bonekamp D, Forsting M, Wetter A, Reis H, Hadaschik BA, Haubold J, Radtke JP. Darr C, et al. Among authors: haubold j. Eur Urol Oncol. 2022 Jun;5(3):357-361. doi: 10.1016/j.euo.2020.08.004. Epub 2020 Aug 29. Eur Urol Oncol. 2022. PMID: 32873530
83 results